Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia (2022)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; SILVA, JEAN CARLOS LIPRERI DA - ICB ; VICARI, HUGO PASSOS - ICB
- Unidades: FM; ICB
- DOI: 10.1016/j.lfs.2022.121146
- Subjects: FARMACOLOGIA; DOENÇAS HEMATOLÓGICAS; LEUCEMIA; LINFÓCITOS B; ONCOGENES; CÉLULAS CULTIVADAS DE TUMOR; APOPTOSE; LINFOMA; MEMBRANA PLASMÁTICA
- Keywords: NEOPLASIAS SANGUINEAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2022
- Source:
- Título: Life Sciences
- ISSN: 1879-0631
- Volume/Número/Paginação/Ano: v. 311, part B, art. 121146, p. 1-9, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SILVA, Jean Carlos Lipreri da et al. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sciences, v. 311, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2022.121146. Acesso em: 11 fev. 2026. -
APA
Silva, J. C. L. da, Araujo, F. S., Melo, R. C. B. de, Vicari, H. P., Carvalho, A. E. S., Rego, E. M., et al. (2022). Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sciences, 311, 1-9. doi:10.1016/j.lfs.2022.121146 -
NLM
Silva JCL da, Araujo FS, Melo RCB de, Vicari HP, Carvalho AES, Rego EM, Buccheri V, Machado Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia [Internet]. Life Sciences. 2022 ; 311 1-9.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1016/j.lfs.2022.121146 -
Vancouver
Silva JCL da, Araujo FS, Melo RCB de, Vicari HP, Carvalho AES, Rego EM, Buccheri V, Machado Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia [Internet]. Life Sciences. 2022 ; 311 1-9.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1016/j.lfs.2022.121146 - New molecular targets in acute leukemias: cytoskeletal regulatory proteins
- Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
- CDC7 (cell division cycle 7)
- Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes
- Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells
- Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells
- ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
- Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia
- Investigação da inibição de ezrina como potencial alvo farmacológico em neoplasias hematológicas
- Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents
Informações sobre o DOI: 10.1016/j.lfs.2022.121146 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
